DRI Healthcare Trust (TSE:DHT.UN) Price Target Cut to C$17.50 by Analysts at National Bankshares

DRI Healthcare Trust (TSE:DHT.UN) had its price target reduced by analysts at National Bankshares from C$19.50 to C$17.50 in a research report issued on Thursday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bankshares’ price target would suggest a potential upside of 48.56% from the stock’s current price.

A number of other research firms have also recently commented on DHT.UN. CIBC cut their price target on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating on the stock in a report on Thursday, December 12th. Raymond James dropped their target price on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of C$17.94.

DRI Healthcare Trust Trading Down 0.6 %

Shares of TSE DHT.UN traded down C$0.07 during mid-day trading on Thursday, reaching C$11.78. The company had a trading volume of 19,006 shares, compared to its average volume of 38,299. The business’s 50-day moving average is C$11.98 and its 200-day moving average is C$12.57. DRI Healthcare Trust has a 52 week low of C$10.39 and a 52 week high of C$17.43.

About DRI Healthcare Trust

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.